I received my undergraduate AB degree in Biochemistry cum laude, with distinction in all subjects and Phi Beta Kappa in 1977 from Cornell University in Ithaca, New York and then went to the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania receiving my MD in 1981 and was elected to Alpha Omega Alpha. I did my medical residency at the Hospital of the University of Pennsylvania from 1981-84 and received my Cardiology training at the Washington University School of Medicine/Barnes Hospital in St. Louis, Missouri from 1984-87, where I first learned about Cardiac Transplantation. I joined the Cardiology Division at the University of Pennsylvania as Medical Co-Director of the Cardiac Transplant Program and Assistant Professor of Medicine from 1987-1993. In 1993, I became the Medical Director of the Advanced Heart Failure and Cardiac Transplant Programs at Temple University School of Medicine and Professor of Medicine and Physiology. At Temple, I led the largest cardiac transplant program in the United States, was a leader of the everolimus clinical trial published in the NEJM and was in leadership positions for several other cardiac transplant clinical trials. In 2005, I became Chief of the Cardiology Division at the Drexel University College of Medicine where I had two endowed chairs. I led the largest clinical trial in cardiac transplant patients. I have been a grant reviewer for the NIH including in Transplant Grant related study sections. I was Professor of Medicine (tenured) and Medical Director of the Cardiac Transplant, MCS and Advanced Heart Failure Programs at the Pennsylvania State/Hershey Medical Center and have since joined Thomas Jefferson University where I am Director of Research in the Jefferson Heart Institute and actively involved the care of cardiac transplant patients, resulting in an increase in the number of number of cardiac transplant recipients and improved cardiac transplant outcomes for 2025. I was also involved in the evaluation of and care of Jefferson’s first heart-liver and heart-lung transplant recipients in 2025. At Jefferson, I have been the primary Cardiology consultant for cardiac clearance of renal and liver transplant candidates at Thomas Jefferson University Hospital. I have ensured that pre- and post-transplant outcomes have been excellent especially from a cardiac standpoint. This resulted in the establishment of the Transplant Consultative Cardiology Program.
Advertisements
